Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6929297 | 1.00 | PAOX (0.31) | PAOX | |
| SCHEMBL9361770 | 1.00 | PAOX (0.31) | PAOX | |
| SCHEMBL9362507 | 1.00 | PAOX (0.31) | PAOX | |
| SCHEMBL9365395 | 1.00 | PAOX (0.31) | PAOX | |
| SCHEMBL10424508 | 1.00 | PAOX (0.31) | PAOX | |
| SCHEMBL987504 | 1.00 | — | — | |
| SCHEMBL1694201 | 1.00 | PAOX (0.31) | PAOX | |
| SCHEMBL9365366 | 1.00 | PAOX (0.31) | PAOX | |
| SCHEMBL9362505 | 1.00 | PAOX (0.31) | PAOX | |
| SCHEMBL632214 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2690085-B1 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | UNIV SANGMYUNG SEOUL INDUSTRY ACADEMY COOPERATION FOUNDATION (KR) | 2016-01-20 | — | — | EP | claimed |
| US-9205232-B2 | Balloon for catheter and balloon catheter | TERUMO KABUSHIKI KAISHA (JP) | 2015-12-08 | — | — | US | claimed |
| US-20150152039-A1 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | SANGMYUNG UNIVERSITY SEOUL INDUSTRY-ACADEMY COOPERATION FOUNDATION (KR) | 2015-06-04 | — | — | US | claimed |
| EP-2690085-A2 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | Sangmyung University Seoul Industry-Academy Cooperation Foundation (KR) | 2014-01-29 | — | — | EP | claimed |
| US-20140018568-A1 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2014-01-16 | — | — | US | claimed |
| US-20130085519-A1 | BALLOON FOR CATHETER AND BALLOON CATHETER | TERUMO KABUSHIKI KAISHA (JP) | 2013-04-04 | — | — | US | claimed |
| US-5563151-A | PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS; ANTIINFLAMMATORY AGENTS, ANALGESICS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1996-10-08 | — | — | US | claimed |
| EP-0623116-A1 | AMINO ACID DERIVATIVES AS PAF-RECEPTOR ANTAGONISTS | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1994-11-09 | — | — | EP | claimed |
| WO-1993014072-A1 | AMINO ACID DERIVATIVES AS PAF-RECEPTOR ANTAGONISTS | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1993-07-22 | — | — | WO | claimed |
| WO-2024071115-A1 | MEDICAL LONG BODY, AND BALLOON CATHETER | テルモ株式会社 | 2024-04-04 | — | — | WO | disclosed |
| WO-2024071117-A1 | BALLOON CATHETER | テルモ株式会社 | 2024-04-04 | — | — | WO | disclosed |
| US-20230127105-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-4156366-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY | Mitsubishi Chemical Corporation (JP) | 2023-03-29 | — | — | EP | disclosed |
| CN-115668570-A | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | 三菱化学株式会社 | 2023-01-31 | — | — | CN | disclosed |
| EP-0405788-A2 | Di-tert-butyl(hydroxy)phenylthio substituted hydroxamic acid derivatives | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1991-01-02 | — | — | EP | disclosed |
| US-4892680-A | OXIDATION RESISTANCE | NIPPON OIL CO., LTD. (JP) | 1990-01-09 | — | — | US | disclosed |
| EP-0285267-A2 | Pyridine derivatives for treatment and prevention of liver damage, and their preparation | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-10-05 | — | — | EP | disclosed |
| EP-0276552-A1 | 1,4-dihydropyridine derivatives and their production | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-03 | — | — | EP | disclosed |
| EP-0109955-B1 | RUBBER/METAL COMPOSITES | MONSANTO EUROPE S.A./N.V. (BE) | 1988-01-20 | — | — | EP | disclosed |
| EP-0109955-A2 | Rubber/metal composites | MONSANTO EUROPE S.A./N.V. (BE) | 1984-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152039-A1 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | NOTUM, UGT1A8, CYP19A1 | PAOX 295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.